Sera Prognostics Inc (SERA NASDAQ) stock market data APIs
$2.8457
-0.06(-2.1%)
as of July 11, 2025
Try our APIs with
free plan!
Sera Prognostics Inc Financial Data Overview
Price chart is built with
Anychart
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Prev. Close
2.8457
Open
2.7863
High
2.8457
Low
2.7035
52 wk Range
1.37-9.1297
Market Cap
107 M
Shares Outstanding
36 705 K
Revenue
115 K
EPS
-0.2
Beta
0.714
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sera Prognostics Inc data using free add-ons & libraries
Get Sera Prognostics Inc Fundamental Data
Sera Prognostics Inc Fundamental data includes:
- Net Revenue: 115 K
- EBITDA: -36 000 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: -0.27
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sera Prognostics Inc News
New
Insider Sale: Chief Financial Officer of $SERA Sells 945 Shares
Austin Aerts, the Chief Financial Officer of $SERA, sold 945 shares of the company on 06-10-2025 for an estimated $1,398. We received data on the trade from a recent SEC filing. This was a sale of app...
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN
SALT LAKE CITY, March 19, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomar...
3 Stocks Under $10 With the Potential to Make You a Millionaire
Buying stocks that can make you millions is any investor’s dream. That is why some investors consider micro-cap or small-cap stocks trading under $10. Doing so lets them buy into the business and po...
Sera Prognostics, Inc. (SERA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Sera Prognostics, Inc. (SERA) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2022. This widely-known consensus outlo...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
